FNY Investment Advisers Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$30.4M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
+$10.5M |
| 3 |
WMGI
Wright Medical Group Inc
WMGI
|
+$9.04M |
| 4 |
ARQL
Arqule Inc
ARQL
|
+$5.39M |
| 5 |
RH
RH
|
+$4.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$63.6M |
| 2 |
Virgin Galactic
SPCE
|
+$11.2M |
| 3 |
PVT
Pivotal Acquisition Corp.
PVT
|
+$9.05M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.37M |
| 5 |
AGN
Allergan plc
AGN
|
+$8.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.38% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Technology | 10.12% |
| 4 | Financials | 5.73% |
| 5 | Materials | 5.48% |
Similar funds
FNY Investment Advisers's Q4 2019 Portfolio in Review
As of Q4 2019, FNY Investment Advisers held 1,291 positions worth $323M, down 1.3% from $327M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
FNY Investment Advisers withdrew a net $29.9M in Q4 2019, closing 456 positions and reducing 143 holdings. Its most notable exit was Celgene Corp, an estimated $63.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, FNY Investment Advisers opened a new position in Alibaba worth $34.4M.
- FNY Investment Advisers's largest Q4 2019 buy was Alibaba: 162,079 shares worth $34.4M.
- FNY Investment Advisers added most to Ryanair in Q4 2019, an estimated $4.47M increase.
- FNY Investment Advisers's biggest Q4 2019 reduction was Virgin Galactic, cutting an estimated $11.2M.
- FNY Investment Advisers fully exited Celgene Corp in Q4 2019, selling an estimated $63.6M.
- FNY Investment Advisers's ten largest holdings make up 39% of its $323M portfolio in Q4 2019.
- FNY Investment Advisers opened 395 new positions and closed 456 in Q4 2019.
- FNY Investment Advisers's portfolio value fell 1.3% quarter-over-quarter to $323M.
Based on FNY Investment Advisers's 13F filing for Q4 2019, filed 10 Jan 2020.